PL1989214T3 - Proces otrzymywania agonisty receptora adenozynowego a2a i jego polimorfów - Google Patents
Proces otrzymywania agonisty receptora adenozynowego a2a i jego polimorfówInfo
- Publication number
- PL1989214T3 PL1989214T3 PL07763545T PL07763545T PL1989214T3 PL 1989214 T3 PL1989214 T3 PL 1989214T3 PL 07763545 T PL07763545 T PL 07763545T PL 07763545 T PL07763545 T PL 07763545T PL 1989214 T3 PL1989214 T3 PL 1989214T3
- Authority
- PL
- Poland
- Prior art keywords
- polymorphs
- preparing
- receptor agonist
- adenosine receptor
- adenosine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/167—Purine radicals with ribosyl as the saccharide radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76511406P | 2006-02-03 | 2006-02-03 | |
US80185706P | 2006-05-18 | 2006-05-18 | |
EP07763545.6A EP1989214B8 (en) | 2006-02-03 | 2007-02-02 | Process for preparing an a2a-adenosine receptor agonist and its polymorphs |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1989214T3 true PL1989214T3 (pl) | 2017-07-31 |
Family
ID=38120353
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL07763545T PL1989214T3 (pl) | 2006-02-03 | 2007-02-02 | Proces otrzymywania agonisty receptora adenozynowego a2a i jego polimorfów |
Country Status (18)
Country | Link |
---|---|
US (8) | US7732595B2 (pl) |
EP (2) | EP1989214B8 (pl) |
JP (3) | JP5326156B2 (pl) |
KR (2) | KR20080090491A (pl) |
CN (1) | CN102260311A (pl) |
AU (1) | AU2007212542B2 (pl) |
CA (1) | CA2640089C (pl) |
ES (1) | ES2593028T3 (pl) |
HK (1) | HK1127358A1 (pl) |
IL (2) | IL193153A (pl) |
MX (1) | MX2010014060A (pl) |
NO (1) | NO341322B1 (pl) |
NZ (1) | NZ570239A (pl) |
PL (1) | PL1989214T3 (pl) |
PT (1) | PT1989214T (pl) |
RU (1) | RU2447081C2 (pl) |
SI (1) | SI1989214T1 (pl) |
WO (1) | WO2007092372A1 (pl) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6403567B1 (en) | 1999-06-22 | 2002-06-11 | Cv Therapeutics, Inc. | N-pyrazole A2A adenosine receptor agonists |
USRE47351E1 (en) | 1999-06-22 | 2019-04-16 | Gilead Sciences, Inc. | 2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists |
CA2439222C (en) | 2000-02-23 | 2009-07-14 | Cv Therapeutics, Inc. | Identification of partial agonists of the a2a adenosine receptor |
US8470801B2 (en) | 2002-07-29 | 2013-06-25 | Gilead Sciences, Inc. | Myocardial perfusion imaging methods and compositions |
MXPA05001123A (es) * | 2002-07-29 | 2005-04-29 | Cv Therapeutics Inc | Formacion de imagenes por perfusion de miocardio mediante el uso de agonistas receptores de a2a. |
US20050020915A1 (en) * | 2002-07-29 | 2005-01-27 | Cv Therapeutics, Inc. | Myocardial perfusion imaging methods and compositions |
JP2008517063A (ja) * | 2004-10-20 | 2008-05-22 | シーブイ・セラピューティクス・インコーポレイテッド | A2aアデノシンレセプターアゴニストの使用 |
PL1989214T3 (pl) * | 2006-02-03 | 2017-07-31 | Gilead Sciences, Inc. | Proces otrzymywania agonisty receptora adenozynowego a2a i jego polimorfów |
JP2009541354A (ja) * | 2006-06-22 | 2009-11-26 | シーブイ・セラピューティクス・インコーポレイテッド | 虚血の治療におけるa2aアデノシン受容体アゴニストの使用 |
EP2056834B1 (en) * | 2006-09-01 | 2012-08-29 | Gilead Sciences, Inc. | Methods and compositions for increasing patient tolerability during myocardial imaging methods |
US20090081120A1 (en) * | 2006-09-01 | 2009-03-26 | Cv Therapeutics, Inc. | Methods and Compositions for Increasing Patient Tolerability During Myocardial Imaging Methods |
JP2011502101A (ja) * | 2006-09-29 | 2011-01-20 | ギリアード・パロ・アルト・インコーポレイテッド | 肺疾患の病歴を有する患者における心筋画像化法 |
CA2673653A1 (en) * | 2007-01-03 | 2008-07-17 | Cv Therapeutics, Inc. | Myocardial perfusion imaging |
CA2685589C (en) * | 2007-05-17 | 2014-09-16 | Cv Therapeutics, Inc. | Process for preparing an a2a-adenosine receptor agonist and its polymorphs |
EP2225255A4 (en) * | 2007-12-20 | 2011-07-20 | King Pharmaceuticals Res & Dev | CRYSTALLINE FORMS OF 2- [2- (4-CHLOROPHENYL) ETHOXY] ADENOSINE |
CA2716501A1 (en) * | 2008-02-29 | 2009-09-03 | King Pharmaceuticals Research And Development, Inc. | Crystal forms of 2-{2-[(cyclohexyl)methylene]hydrazino}adenosine |
JP5709743B2 (ja) * | 2008-06-06 | 2015-04-30 | ハーバー セラピューティクス, インコーポレイテッド | 17−アルキニル−7−ヒドロキシステロイドおよび関連する化合物の調製方法 |
US20100086483A1 (en) * | 2008-09-29 | 2010-04-08 | Gilead Palo Alto, Inc. | Method of multidetector computed tomagraphy |
US8859522B2 (en) | 2011-04-27 | 2014-10-14 | Reliable Biopharmaceutical Corporation | Processes for the preparation of regadenoson and a new crystalline form thereof |
CZ308577B6 (cs) * | 2011-08-18 | 2020-12-16 | Farmak, A. S. | Způsob přípravy 2-(4-methoxykarbonylpyrazol-1-yl)adenosinu a 2-(4-ethoxykarbonylpyrazol-1-yl)adenosinu |
CZ304053B6 (cs) * | 2011-08-22 | 2013-09-04 | Farmak, A. S. | Zpusob prípravy 2-[4-[(methylamino)karbonyl]-1-H-pyrazol-1-yl]adenosinu monohydrátu |
EP2908858B1 (en) | 2012-10-19 | 2020-06-24 | New York University | Compositions for use in inhibiting osteolysis |
EP2789624B1 (en) * | 2013-04-11 | 2020-09-23 | AMRI Italy S.r.l. | Stable solid forms of regadenoson |
CZ305213B6 (cs) | 2013-04-29 | 2015-06-10 | Farmak, A. S. | Polymorf E 2-[4-[(methylamino)karbonyl]-1H-pyrazol-1-yl]adenosinu a způsob jeho přípravy |
EP3003320A4 (en) * | 2013-05-30 | 2016-10-19 | Biophore India Pharmaceuticals Pvt Ltd | NEW POLYMORPHE OF REGADENOSON |
US9771390B2 (en) | 2013-12-10 | 2017-09-26 | Scinopharm Taiwan, Ltd. | Process for the preparation of regadenoson |
CN105085593A (zh) * | 2014-04-21 | 2015-11-25 | 上海紫源制药有限公司 | 瑞加德松的晶型及其制备方法 |
CN105198950B (zh) * | 2014-06-17 | 2018-10-02 | 上海紫源制药有限公司 | 一种瑞加德松晶型e的制备方法 |
CN105175468B (zh) * | 2014-06-17 | 2018-06-19 | 上海紫源制药有限公司 | 一种瑞加德松晶型b的制备方法 |
US10442832B2 (en) | 2015-02-06 | 2019-10-15 | Apicore Us Llc | Process of making regadenoson and novel polymorph thereof |
US9809617B2 (en) | 2015-07-03 | 2017-11-07 | Shanghai Ziyuan Pharmaceutical Co., Ltd. | Crystal form of regadenoson and preparation method thereof |
CN106397442B (zh) * | 2015-07-28 | 2020-03-27 | 国药集团国瑞药业有限公司 | 一种瑞加德松的纯化方法 |
US10392417B2 (en) | 2016-11-04 | 2019-08-27 | Apicore Us Llc | Polymorph of regadenoson and process for preparation thereof |
CN106749254B (zh) * | 2017-01-10 | 2018-05-25 | 青岛科技大学 | 一种6-氨基嘌呤乙基萘乙酸酯类化合物及其作为植物生长调节剂的用途 |
WO2019191389A1 (en) | 2018-03-29 | 2019-10-03 | Johnson Matthey Public Limited Company | Solid-state forms of regadenoson, their use and preparation |
US10815265B2 (en) | 2018-06-29 | 2020-10-27 | Usv Private Limited | Process for preparation of regadenoson and polymorphs thereof |
Family Cites Families (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4826038Y1 (pl) | 1970-12-25 | 1973-07-30 | ||
DK135130B (da) | 1970-12-28 | 1977-03-07 | Takeda Chemical Industries Ltd | Analogifremgangsmåde til fremstilling af 2-substituerede adenosinderivater eller syreadditionssalte deraf. |
BE787064A (fr) | 1971-08-03 | 1973-02-01 | Philips Nv | Dispositif magnetique comportant des domaines |
US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US4120947A (en) | 1976-03-31 | 1978-10-17 | Cooper Laboratories, Inc. | Xanthine compounds and method of treating bronchospastic and allergic diseases |
US4089959A (en) | 1976-03-31 | 1978-05-16 | Cooper Laboratories, Inc. | Long-acting xanthine bronchodilators and antiallergy agents |
SE7810946L (sv) | 1978-10-20 | 1980-04-21 | Draco Ab | Metod att behandla kronisk obstruktiv luftvegssjukdom |
US4326525A (en) | 1980-10-14 | 1982-04-27 | Alza Corporation | Osmotic device that improves delivery properties of agent in situ |
US4593095A (en) | 1983-02-18 | 1986-06-03 | The Johns Hopkins University | Xanthine derivatives |
US5364620A (en) | 1983-12-22 | 1994-11-15 | Elan Corporation, Plc | Controlled absorption diltiazem formulation for once daily administration |
US4696932A (en) | 1984-10-26 | 1987-09-29 | The United States Of America As Represented By The Department Of Health And Human Services | Biologically-active xanthine derivatives |
JPS6299395A (ja) | 1985-10-25 | 1987-05-08 | Yamasa Shoyu Co Ltd | 2−アルキニルアデノシンおよび抗高血圧剤 |
US4968697A (en) | 1987-02-04 | 1990-11-06 | Ciba-Geigy Corporation | 2-substituted adenosine 5'-carboxamides as antihypertensive agents |
US5001139A (en) | 1987-06-12 | 1991-03-19 | American Cyanamid Company | Enchancers for the transdermal flux of nivadipine |
US4992445A (en) | 1987-06-12 | 1991-02-12 | American Cyanamid Co. | Transdermal delivery of pharmaceuticals |
US4990498A (en) | 1988-04-26 | 1991-02-05 | Temple University-Of The Commonwealth System Of Higher Education | 2- and 8-azido(2'-5')oligoadenylates and antiviral uses thereof |
US4902514A (en) | 1988-07-21 | 1990-02-20 | Alza Corporation | Dosage form for administering nilvadipine for treating cardiovascular symptoms |
US5070877A (en) | 1988-08-11 | 1991-12-10 | Medco Research, Inc. | Novel method of myocardial imaging |
DE3831430A1 (de) | 1988-09-15 | 1990-03-22 | Bayer Ag | Substituierte 4-heterocyclyloximino-pyrazolin-5-one, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel |
EP0444196B1 (en) | 1988-11-15 | 1994-06-08 | Yamasa Shoyu Kabushiki Kaisha | Agent for treatment and prophylaxis of ischemic disease of heart or brain |
IT1229195B (it) | 1989-03-10 | 1991-07-25 | Poli Ind Chimica Spa | Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche. |
EP0429681B1 (en) | 1989-06-20 | 1995-09-06 | Yamasa Shoyu Kabushiki Kaisha (Yamasa Corporation) | Intermediate for 2-alkynyladenosine synthesis, production of said intermediate, production of 2-alkynyladenosine from said intermediate, and stable 2-alkynyladenosine derivative |
US5032252A (en) | 1990-04-27 | 1991-07-16 | Mobil Oil Corporation | Process and apparatus for hot catalyst stripping in a bubbling bed catalyst regenerator |
DE4019892A1 (de) | 1990-06-22 | 1992-01-02 | Boehringer Ingelheim Kg | Neue xanthinderivate |
US5189027A (en) | 1990-11-30 | 1993-02-23 | Yamasa Shoyu Kabushiki Kaisha | 2-substituted adenosine derivatives and pharmaceutical compositions for circulatory diseases |
FR2671356B1 (fr) | 1991-01-09 | 1993-04-30 | Inst Nat Sante Rech Med | Procede de description des repertoires d'anticorps (ab) et des recepteurs des cellules t (tcr) du systeme immunitaire d'un individu. |
JP2740362B2 (ja) | 1991-02-12 | 1998-04-15 | ヤマサ醤油株式会社 | 安定な固体状2‐オクチニルアデノシンおよびその製造法 |
JP3053908B2 (ja) | 1991-06-28 | 2000-06-19 | ヤマサ醤油株式会社 | 2‐アルキニルアデノシン誘導体 |
US5516894A (en) | 1992-03-11 | 1996-05-14 | The General Hospital Corporation | A2b -adenosine receptors |
IT1254915B (it) | 1992-04-24 | 1995-10-11 | Gloria Cristalli | Derivati di adenosina ad attivita' a2 agonista |
GB9210839D0 (en) | 1992-05-21 | 1992-07-08 | Smithkline Beecham Plc | Novel compounds |
JPH08500967A (ja) | 1992-06-12 | 1996-02-06 | ガーヴァン インスティチュート オブ メディカル リサーチ | ヒトA1,A2aおよびA2bアデノシン受容体をエンコードするDNA配列 |
EP0601322A3 (en) | 1992-10-27 | 1994-10-12 | Nippon Zoki Pharmaceutical Co | Adenosine deaminase inhibitor. |
CA2112031A1 (en) | 1992-12-24 | 1994-06-25 | Fumio Suzuki | Xanthine derivatives |
US5477857A (en) | 1993-09-10 | 1995-12-26 | Discovery Therapeutics, Inc. | Diagnostic uses of hydrazinoadenosines |
WO1995011681A1 (en) | 1993-10-29 | 1995-05-04 | Merck & Co., Inc. | Human adenosine receptor antagonists |
US5703085A (en) | 1994-02-23 | 1997-12-30 | Kyowa Hakko Kogyo Co., Ltd. | Xanthine derivatives |
US5704491A (en) | 1995-07-21 | 1998-01-06 | Cummins-Allison Corp. | Method and apparatus for discriminating and counting documents |
US5646156A (en) | 1994-04-25 | 1997-07-08 | Merck & Co., Inc. | Inhibition of eosinophil activation through A3 adenosine receptor antagonism |
US5877180A (en) | 1994-07-11 | 1999-03-02 | University Of Virginia Patent Foundation | Method for treating inflammatory diseases with A2a adenosine receptor agonists |
US6448235B1 (en) | 1994-07-11 | 2002-09-10 | University Of Virginia Patent Foundation | Method for treating restenosis with A2A adenosine receptor agonists |
US6514949B1 (en) | 1994-07-11 | 2003-02-04 | University Of Virginia Patent Foundation | Method compositions for treating the inflammatory response |
US5854081A (en) | 1996-06-20 | 1998-12-29 | The University Of Patent Foundation | Stable expression of human A2B adenosine receptors, and assays employing the same |
US5780481A (en) | 1996-08-08 | 1998-07-14 | Merck & Co., Inc. | Method for inhibiting activation of the human A3 adenosine receptor to treat asthma |
US5776960A (en) | 1996-10-16 | 1998-07-07 | Buckman Laboratories International, Inc. | Synergistic antimicrobial compositions containing an ionene polymer and a pyrithione salt and methods of using the same |
US5770716A (en) | 1997-04-10 | 1998-06-23 | The Perkin-Elmer Corporation | Substituted propargylethoxyamido nucleosides, oligonucleotides and methods for using same |
EP0983768A1 (en) | 1997-05-23 | 2000-03-08 | Nippon Shinyaku Co., Ltd. | Medicinal composition for prevention or treatment of hepatopathy |
JP2002505687A (ja) | 1997-06-18 | 2002-02-19 | ディスカバリー セラピューティクス,インコーポレイテッド | 脈管再生手順の後の再狭窄を防止するための組成物および方法 |
US6026317A (en) | 1998-02-06 | 2000-02-15 | Baylor College Of Medicine | Myocardial perfusion imaging during coronary vasodilation with selective adenosine A2 receptor agonists |
US6117878A (en) | 1998-02-24 | 2000-09-12 | University Of Virginia | 8-phenyl- or 8-cycloalkyl xanthine antagonists of A2B human adenosine receptors |
WO1999063938A2 (en) | 1998-06-08 | 1999-12-16 | Epigenesis Pharmaceuticals, Inc. | Composition and method for prevention and treatment of cardiopulmonary and renal failure or damage associated with ischemia, endotoxin release, ards or brought about by administration of certain drugs |
GB9913932D0 (en) * | 1999-06-15 | 1999-08-18 | Pfizer Ltd | Purine derivatives |
US6322771B1 (en) | 1999-06-18 | 2001-11-27 | University Of Virginia Patent Foundation | Induction of pharmacological stress with adenosine receptor agonists |
US6214807B1 (en) | 1999-06-22 | 2001-04-10 | Cv Therapeutics, Inc. | C-pyrazole 2A A receptor agonists |
US6403567B1 (en) | 1999-06-22 | 2002-06-11 | Cv Therapeutics, Inc. | N-pyrazole A2A adenosine receptor agonists |
NZ517546A (en) | 1999-08-31 | 2003-10-31 | Univ Vanderbilt | Selective antagonists of A2B adenosine receptors |
US6368573B1 (en) | 1999-11-15 | 2002-04-09 | King Pharmaceuticals Research And Development, Inc. | Diagnostic uses of 2-substituted adenosine carboxamides |
US6605597B1 (en) | 1999-12-03 | 2003-08-12 | Cv Therapeutics, Inc. | Partial or full A1agonists-N-6 heterocyclic 5′-thio substituted adenosine derivatives |
US6294522B1 (en) | 1999-12-03 | 2001-09-25 | Cv Therapeutics, Inc. | N6 heterocyclic 8-modified adenosine derivatives |
US6677336B2 (en) | 2000-02-22 | 2004-01-13 | Cv Therapeutics, Inc. | Substituted piperazine compounds |
US6552023B2 (en) | 2000-02-22 | 2003-04-22 | Cv Therapeutics, Inc. | Aralkyl substituted piperazine compounds |
CA2439222C (en) | 2000-02-23 | 2009-07-14 | Cv Therapeutics, Inc. | Identification of partial agonists of the a2a adenosine receptor |
US6387913B1 (en) | 2000-12-07 | 2002-05-14 | S. Jamal Mustafa | Method of treating airway diseases with combined administration of A2B and A3 adenosine receptor antagonists |
US6670334B2 (en) | 2001-01-05 | 2003-12-30 | University Of Virginia Patent Foundation | Method and compositions for treating the inflammatory response |
US6758388B1 (en) | 2001-02-27 | 2004-07-06 | Rohr, Inc. | Titanium aluminide honeycomb panel structures and fabrication method for the same |
US6995148B2 (en) | 2001-04-05 | 2006-02-07 | University Of Pittsburgh | Adenosine cyclic ketals: novel adenosine analogues for pharmacotherapy |
US6599283B1 (en) | 2001-05-04 | 2003-07-29 | Cv Therapeutics, Inc. | Method of preventing reperfusion injury |
CN1268610C (zh) | 2001-05-14 | 2006-08-09 | 诺瓦提斯公司 | 磺酰胺衍生物 |
US7125993B2 (en) | 2001-11-09 | 2006-10-24 | Cv Therapeutics, Inc. | A2B adenosine receptor antagonists |
US6977300B2 (en) | 2001-11-09 | 2005-12-20 | Cv Therapeutics, Inc. | A2B adenosine receptor antagonists |
IL161867A0 (en) | 2001-11-09 | 2005-11-20 | Cv Therapeutics Inc | A2b adenosine receptor antagonists |
EP1465631B1 (en) | 2001-12-20 | 2010-02-24 | OSI Pharmaceuticals, Inc. | Pyrimidine a2b selective antagonist compounds, their synthesis and use |
WO2003086451A1 (en) | 2002-04-05 | 2003-10-23 | Centocor, Inc. | Asthma-related anti-il-13 immunoglobulin derived proteins, compositions, methods and uses |
EP1494685B1 (en) | 2002-04-18 | 2008-12-31 | Cv Therapeutics, Inc. | Method of treating arrhythmias comprising administration of an a1 adenosine agonist with a beta blocker |
MXPA05001123A (es) | 2002-07-29 | 2005-04-29 | Cv Therapeutics Inc | Formacion de imagenes por perfusion de miocardio mediante el uso de agonistas receptores de a2a. |
US8470801B2 (en) | 2002-07-29 | 2013-06-25 | Gilead Sciences, Inc. | Myocardial perfusion imaging methods and compositions |
US20050020915A1 (en) | 2002-07-29 | 2005-01-27 | Cv Therapeutics, Inc. | Myocardial perfusion imaging methods and compositions |
WO2005082379A1 (en) | 2004-01-27 | 2005-09-09 | Cv Therapeutics, Inc. | Myocardial perfusion imaging using adenosine receptor agonists |
AU2005295654B2 (en) | 2004-10-15 | 2011-04-14 | Gilead Sciences, Inc. | Method of preventing and treating airway remodeling and pulmonary inflammation using A2B adenosine receptor antagonists |
JP2008517063A (ja) | 2004-10-20 | 2008-05-22 | シーブイ・セラピューティクス・インコーポレイテッド | A2aアデノシンレセプターアゴニストの使用 |
US20060159621A1 (en) | 2005-01-12 | 2006-07-20 | Barrett Richard J | Method of detecting myocardial dysfunction in patients having a history of asthma or bronchospasm |
US20070114269A1 (en) | 2005-11-22 | 2007-05-24 | Straza George C | Formed metal core sandwich structure and method and system for making same |
PL1989214T3 (pl) | 2006-02-03 | 2017-07-31 | Gilead Sciences, Inc. | Proces otrzymywania agonisty receptora adenozynowego a2a i jego polimorfów |
JP2009541354A (ja) | 2006-06-22 | 2009-11-26 | シーブイ・セラピューティクス・インコーポレイテッド | 虚血の治療におけるa2aアデノシン受容体アゴニストの使用 |
EP2056834B1 (en) | 2006-09-01 | 2012-08-29 | Gilead Sciences, Inc. | Methods and compositions for increasing patient tolerability during myocardial imaging methods |
US20090081120A1 (en) | 2006-09-01 | 2009-03-26 | Cv Therapeutics, Inc. | Methods and Compositions for Increasing Patient Tolerability During Myocardial Imaging Methods |
JP2011502101A (ja) | 2006-09-29 | 2011-01-20 | ギリアード・パロ・アルト・インコーポレイテッド | 肺疾患の病歴を有する患者における心筋画像化法 |
CA2673653A1 (en) | 2007-01-03 | 2008-07-17 | Cv Therapeutics, Inc. | Myocardial perfusion imaging |
CA2685589C (en) | 2007-05-17 | 2014-09-16 | Cv Therapeutics, Inc. | Process for preparing an a2a-adenosine receptor agonist and its polymorphs |
WO2009076580A2 (en) | 2007-12-12 | 2009-06-18 | Thomas Jefferson University | Compositions and methods for the treatment and prevention of cardiovascular diseases |
US20100086483A1 (en) | 2008-09-29 | 2010-04-08 | Gilead Palo Alto, Inc. | Method of multidetector computed tomagraphy |
WO2014068589A2 (en) * | 2012-10-29 | 2014-05-08 | Biophore India Pharmaceuticals Pvt. Ltd. | Novel process for the preparation of (1-{9-[(4s, 2r, 3r, 5r)-3, 4-dihydroxy-5-(hydroxymethyl) oxolan-2-yl)-6-aminopurin-2-yl} pyrazole-4-yl)-n-methylcarboxamide |
CZ305213B6 (cs) * | 2013-04-29 | 2015-06-10 | Farmak, A. S. | Polymorf E 2-[4-[(methylamino)karbonyl]-1H-pyrazol-1-yl]adenosinu a způsob jeho přípravy |
EP3003320A4 (en) * | 2013-05-30 | 2016-10-19 | Biophore India Pharmaceuticals Pvt Ltd | NEW POLYMORPHE OF REGADENOSON |
US9771390B2 (en) * | 2013-12-10 | 2017-09-26 | Scinopharm Taiwan, Ltd. | Process for the preparation of regadenoson |
-
2007
- 2007-02-02 PL PL07763545T patent/PL1989214T3/pl unknown
- 2007-02-02 JP JP2008553396A patent/JP5326156B2/ja active Active
- 2007-02-02 RU RU2008131956/04A patent/RU2447081C2/ru active
- 2007-02-02 NZ NZ570239A patent/NZ570239A/en unknown
- 2007-02-02 US US11/701,699 patent/US7732595B2/en active Active
- 2007-02-02 PT PT77635456T patent/PT1989214T/pt unknown
- 2007-02-02 SI SI200731820A patent/SI1989214T1/sl unknown
- 2007-02-02 EP EP07763545.6A patent/EP1989214B8/en active Active
- 2007-02-02 CA CA2640089A patent/CA2640089C/en active Active
- 2007-02-02 ES ES07763545.6T patent/ES2593028T3/es active Active
- 2007-02-02 EP EP12008201.1A patent/EP2581381A3/en not_active Withdrawn
- 2007-02-02 CN CN2011101265472A patent/CN102260311A/zh active Pending
- 2007-02-02 WO PCT/US2007/003022 patent/WO2007092372A1/en active Application Filing
- 2007-02-02 KR KR1020087019013A patent/KR20080090491A/ko not_active Application Discontinuation
- 2007-02-02 AU AU2007212542A patent/AU2007212542B2/en active Active
- 2007-02-02 KR KR1020137028337A patent/KR101494125B1/ko active IP Right Grant
- 2007-05-17 US US11/750,295 patent/US7671192B2/en active Active
-
2008
- 2008-07-31 IL IL193153A patent/IL193153A/en active IP Right Grant
- 2008-08-01 NO NO20083395A patent/NO341322B1/no unknown
-
2009
- 2009-05-05 HK HK09104112.6A patent/HK1127358A1/zh unknown
-
2010
- 2010-01-13 US US12/687,077 patent/US7956179B2/en active Active
- 2010-04-22 US US12/765,623 patent/US8106183B2/en active Active
- 2010-12-16 MX MX2010014060A patent/MX2010014060A/es active IP Right Grant
-
2011
- 2011-04-22 US US13/092,812 patent/US8268988B2/en active Active
- 2011-12-21 US US13/333,872 patent/US8524883B2/en active Active
-
2012
- 2012-10-11 JP JP2012226344A patent/JP2013010791A/ja not_active Withdrawn
- 2012-10-11 JP JP2012226343A patent/JP2013014620A/ja not_active Withdrawn
-
2013
- 2013-08-19 US US13/970,372 patent/US9085601B2/en not_active Ceased
-
2017
- 2017-06-06 IL IL252700A patent/IL252700A0/en unknown
- 2017-07-19 US US15/653,860 patent/USRE47301E1/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL252700A0 (en) | A process for preparing an adenosine a2a receptor agonist and its polymorphs | |
HK1140771A1 (en) | Process for preparing an a2a-adenosine receptor agonist and its polymorphs a2a- | |
EP2151236A4 (en) | G PROTEIN COUPLED RECEPTOR AGONIST | |
IL192573A0 (en) | Process for preparing substituted biphenyls | |
ZA201001874B (en) | Nmda receptor antagonists for neuroprotection | |
GB0607196D0 (en) | G-protein coupled receptor agonists | |
EP1987523A4 (en) | PROCESS AND DEVICE FOR IMAGING | |
HK1158628A1 (en) | Process for preparing dihydropteridinone derivatives | |
ZA201003439B (en) | Novel glucocorticoid receptor agonists | |
IL198117A0 (en) | Process for preparing indol-5-oxy-quinazoline derivatives and intermediates | |
PL2213654T3 (pl) | Sposób wytwarzania pochodnych 2-amino-5-bromobenzamidu | |
EP2019118A4 (en) | METHOD FOR SYNTHETIZING THYMOSINS | |
ZA200806666B (en) | Process for preparing an A2A-adenosine receptor agonist and its polymorphs | |
HK1111160A1 (en) | Process for preparing | |
HK1148228A1 (en) | Method for preparing optionally substituted p-hydroxymandelic compounds and derivatives thereof | |
GB2456999B (en) | Method for preparing 2-deoxy-L-ribose | |
GB2436466B (en) | Feeder apparatus | |
EP2101618A4 (en) | APPARATUS FOR RETAINING SUBSTANTIALLY CYLINDRICALLY SHAPED ELEMENTS | |
ZA201000397B (en) | Process for preparing oxazolidine-and oxazolidinone-aminodiols and related intermediates | |
ZA200805781B (en) | Process for preparing substituted biphenyls | |
EP2163557A4 (en) | FUNCTIONAL DETECTIVE VITAMIN D RECEPTOR AGONISTS | |
IL195262A0 (en) | Process for preparing hydroxylpatite | |
IL200389A0 (en) | Process for preparing substituted phenylhydrazines | |
GB0700770D0 (en) | Apparatus for detecting retinal neuropathy | |
EP2339030A4 (en) | SCREENING PROCESS FOR LIVER X RECEPTOR AGONISTS AND APPLICATION THEREOF |